Lu S
J Fungi (Basel). 2021; 7(7).
PMID: 34356934
PMC: 8306613.
DOI: 10.3390/jof7070555.
Millet N, Solis N, Swidergall M
Front Immunol. 2020; 11:555363.
PMID: 33193324
PMC: 7642201.
DOI: 10.3389/fimmu.2020.555363.
Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova J
Curr Opin Allergy Clin Immunol. 2012; 12(6):616-22.
PMID: 23026768
PMC: 3538358.
DOI: 10.1097/ACI.0b013e328358cc0b.
Cypowyj S, Picard C, Marodi L, Casanova J, Puel A
Eur J Immunol. 2012; 42(9):2246-54.
PMID: 22949323
PMC: 3720135.
DOI: 10.1002/eji.201242605.
Moraes-Vasconcelos D, Costa-Carvalho B, Torgerson T, Ochs H
J Clin Immunol. 2008; 28 Suppl 1:S11-9.
PMID: 18264745
DOI: 10.1007/s10875-008-9176-5.
Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis.
de Moraes-Vasconcelos D, Orii N, Romano C, Iqueoka R, Duarte A
Clin Exp Immunol. 2001; 123(2):247-53.
PMID: 11207655
PMC: 1905973.
DOI: 10.1046/j.1365-2249.2001.01430.x.
Cutaneous defenses against dermatophytes and yeasts.
Wagner D, Sohnle P
Clin Microbiol Rev. 1995; 8(3):317-35.
PMID: 7553568
PMC: 174627.
DOI: 10.1128/CMR.8.3.317.
Humoral and cell-mediated immune responses in chronic typhoid carriers.
Dham S, Thompson R
Clin Exp Immunol. 1982; 50(1):34-40.
PMID: 7172510
PMC: 1536860.
Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects.
Epstein J, Pearsall N, Truelove E
J Clin Microbiol. 1980; 12(3):475-6.
PMID: 7012183
PMC: 273612.
DOI: 10.1128/jcm.12.3.475-476.1980.
Immunity to Candida albicans.
Rogers T, Balish E
Microbiol Rev. 1980; 44(4):660-82.
PMID: 7010113
PMC: 373198.
DOI: 10.1128/mr.44.4.660-682.1980.
Studies on defense mechanisms against Candida albicans infection in congenitally athymic nude (nu/nu) mice.
Tabeta H, Mikami Y, Abe F, Ommura Y, Arai T
Mycopathologia. 1984; 84(2-3):107-13.
PMID: 6717553
DOI: 10.1007/BF00436521.
Quantitative relationships of Candida albicans infections and dressing patterns in Nigerian women.
Elegbe I, Elegbe I
Am J Public Health. 1983; 73(4):450-2.
PMID: 6338749
PMC: 1650765.
DOI: 10.2105/ajph.73.4.450.
Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy.
Zouali M, Drouhet E, EYQUEM A
Mycopathologia. 1984; 84(2-3):87-93.
PMID: 6325916
DOI: 10.1007/BF00436518.
Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.
Fanconi S, Seger R, Joller P, Issler C, Schar G
Eur J Pediatr. 1982; 139(3):176-80.
PMID: 6297913
DOI: 10.1007/BF01377351.
Changing views on oral disease.
Kramer I
Proc R Soc Med. 1974; 67(4):271-6.
PMID: 4616250
PMC: 1645480.
[Kinetic study of the delayed type hypersensitivity in experimental candidiasis of the mouse].
Floch F, Biguet J, Andrieu S, Vernes A
Mycopathol Mycol Appl. 1974; 54(4):475-83.
PMID: 4614089
DOI: 10.1007/BF02050053.
Cell-mediated immunity and antibodies to Herpesvirus hominis type 1 in oral leukoplakia and carcinoma.
Lehner T, Wilton J, Shillitoe E, Ivanyi L
Br J Cancer. 1973; 27(5):351-61.
PMID: 4351511
PMC: 2008806.
DOI: 10.1038/bjc.1973.43.
Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis.
Durandy A, Fischer A, Le Deist F, Drouhet E, Griscelli C
J Clin Immunol. 1987; 7(5):400-9.
PMID: 2958495
DOI: 10.1007/BF00917018.
IgG2/IgG4 subclass deficiency in a patient with chronic mucocutaneous candidiasis and bronchiectases.
Bragger C, Seger R, Aeppli R, Halle F, HITZIG W
Eur J Pediatr. 1989; 149(3):168-9.
PMID: 2612503
DOI: 10.1007/BF01958272.
Chronic mucocutaneous candidiasis.
Kirkpatrick C
Eur J Clin Microbiol Infect Dis. 1989; 8(5):448-56.
PMID: 2502409
DOI: 10.1007/BF01964059.